TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo November 4, 2020 Richard S. Eiswirth, Jr. Chief Executive Officer Alimera Sciences, Inc. 6120 Windward Parkway, Suite 290 Alpharetta, GA 30005 Re: Alimera Sciences, Inc. Registration Statement on Form S-3 Filed November 2, 2020 File No. 333-249804 Dear Mr. Eiswirth: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Charles D. Vaughn, Esq.